NEW YORK (Reuters Health) Jan 10 – Abbott Laboratories said Thursday that it has received US Food and Drug Administration (FDA) clearance for its PathVysion

NEW YORK (MedscapeWire) Jan 08 — When people with lung cancer are treated with radiation therapy, the size of their tumor may be the best

NEW YORK (Reuters Health) Jan 10 – Blocking macrophage inflammatory protein 1-alpha (MIP-1alpha) production by a human myeloma cell line decreases both tumor burden and